SCHEMBL18380986

SCHEMBL18380986

N=Cc1cc(C2CC2)ccc1C(N)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 2/20 0.40
▸ ACMSD Q8TDX5 2/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ PDE4A P27815 1/20 0.35
▸ PDE4B Q07343 1/20 0.35
▸ PDE4C Q08493 1/20 0.35
▸ PDE4D Q08499 1/20 0.35
▸ HDAC3 O15379 1/20 0.34
▸ HDAC1 Q13547 1/20 0.34
▸ HDAC2 Q92769 1/20 0.34
▸ JAK2 O60674 2/20 0.33
▸ JAK1 P23458 2/20 0.33
▸ DGAT1 O75907 1/20 0.33
▸ PARP1 P09874 2/20 0.32
▸ QDPR P09417 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18296100 0.78 KMT2A (0.47) ACMSDCYP2C9KDM4EMAPTKMT2A
SCHEMBL1663250 0.75 ESR2 (0.44) ESR2ACMSDCYP2C9HDAC3HDAC1
SCHEMBL29439363 0.75 DGAT1 (0.53) ACMSDCYP2C9DGAT1PARP15PARP10
SCHEMBL3375579 0.75 DGAT1 (0.53) ACMSDCYP2C9DGAT1PARP15PARP10
SCHEMBL18534840 0.74 HDAC1 (0.38) ESR2HDAC3HDAC1HDAC2QDPR
SCHEMBL20418629 0.73 DGAT1 (0.55) CYP2C9DGAT1PARP1KDM4EMAPT
SCHEMBL28193482 0.71 ACMSD (0.44) ACMSDCYP2C9DGAT1PARP15PARP10
SCHEMBL1785217 0.71 NPSR1 (0.45) ACMSDCYP2C9MAPTKMT2A
SCHEMBL15776230 0.71 ACMSD (0.38) ESR2ACMSDCYP2C9PDE4APDE4B
SCHEMBL18534770 0.70 BACE1 (0.40) ESR2HDAC3HDAC1HDAC2QDPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2838898-B1 SUBSTITUTED HETERO-BICYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF ADVINUS THERAPEUTICS LTD (IN) 2017-01-18 — — EP disclosed
Send feedback